Skip to main content
OpenTrials

Clinical trial condition

Disease Attributes

Explore clinical trials studying Disease Attributes. Study availability and eligibility vary by location and protocol.

21,705 public trials 3,134 recruiting studies
Refine in advanced search Browse all conditions

Disease Attributes trial results

Recruiting

A Study Evaluating the Safety, Efficacy, and Pharmacokinetics of Mosunetuzumab and a Combined Regimen of Mosunetuzumab and Venetoclax in Participants With Relapsed or Refractory Chronic Lymphocytic Leukemia

NCT05091424

Conditions
Chronic Disease, Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma, Disease Attributes, +14 more
Locations
  • Mayo Clinic Rochester Rochester, Minnesota, United States
  • Memorial Sloan-Kettering Cancer Center New York, United States
  • The James Cancer Hospital and Solove Research Institute Columbus, Ohio, United States
  • Uni of Texas - Md Anderson Cancer Center Houston, Texas, United States
View all 31 locations
View Trial Details
Recruiting

A Study of ARV-393 in Relapsed/Refractory Non-Hodgkin Lymphoma.

NCT06393738

Conditions
Disease Attributes, Hemic and Lymphatic Diseases, Immune System Diseases, +15 more
Locations
  • Clinical Trial Site New Haven, Connecticut, United States
  • Clinical Trial Site Detroit, Michigan, United States
  • Clinical Trial Site New Brunswick, New Jersey, United States
  • Clinical Trial Site New York, United States
View all 21 locations
View Trial Details
Recruiting

A Study to Evaluate the Pharmacokinetics and Safety of XEMBIFY Versus Gamunex-C in Participants With Chronic Inflammatory Demyelinating Polyradiculoneuropathy

NCT07540221

Conditions
Autoimmune Diseases, Autoimmune Diseases of the Nervous System, CIDP (Chronic Inflammatory Demyelinating Polyradiculoneuropathy), +12 more
Locations
  • GC2402 Study Site 104 Rancho Mirage, California, United States
  • GC2402 Study Site 109 Coral Springs, Florida, United States
  • GC2402 Study Site 105 Miami, Florida, United States
  • GC2402 Study Site 103 Port Charlotte, Florida, United States
View Trial Details
Recruiting

Study Evaluating the Efficacy of KITE-753 Versus Axicabtagene Ciloleucel in Participants With Relapsed or Refractory Large B-Cell Lymphoma After First-Line Therapy

NCT07479797

Conditions
Disease Attributes, Pathologic Processes, Pathological Conditions, Signs and Symptoms, +2 more
Locations
  • City of Hope (City of Hope National Medical Center, City of Hope Medical Center) Duarte, California, United States
  • Stanford University Stanford, California, United States
  • Colorado Blood Cancer Institute Denver, Colorado, United States
  • Southeastern Regional Medical Center, Inc. dba City of Hope Atlanta Newnan, Georgia, United States
View all 19 locations
View Trial Details

Related conditions